Skip to main content
Clinical Trials/ITMCTR2100004525
ITMCTR2100004525
Recruiting
未知

Key techniques and outcome research for therapeutic effect of traditional Chinese medicine as complex intervention based on holistic system and pattern differentiation & prescription

Beijing University of Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Beijing University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\) Comply with IBS C Roman IV diagnostic standard;
  • 2\) Aged between 18 and 70 years, gender is not limited;
  • 3\) Have not taken any medication related to the disease within at least one week before entering the study, and have not participated in any other ongoing study;
  • 4\) Colonoscopy was performed within 1 year (colon polyps, inflammatory bowel disease and other organic lesions were excluded);
  • 5\) Voluntary subject and informed consent signed by the participant;
  • 6\) Frequent residence in the location of treatment is conducive to treatment and follow\-up.

Exclusion Criteria

  • 1\) Alternate diarrhea and constipation with IBS;
  • 2\) Patients with previous heart, liver and kidney tumors and organic lesions or patients with mental illness;
  • 3\) Patients with previous gastrointestinal tumors and organic lesions, such as pancreatitis, intestinal polyps (not including polypectomy for more than half a month), intestinal diverticulum, history of colon or rectal cancer, inflammatory bowel history, intestinal tuberculosis, etc.;
  • 4\) Previous metabolic diseases affecting digestive tract motility, such as thyroid disease and diabetes mellitus;
  • 5\) People with previous gastrocardiac syndrome and lactase deficiency;
  • 6\) Allergic constitution or allergic to the components of the drug under study;
  • 7\) Pregnant or lactating women, and female patients with recent family planning;
  • 8\) Previous abdominal or pelvic surgery, such as cholecystectomy;
  • 9\) People who are taking other Chinese medicine for treatment;
  • 10\) According to the researchers' judgment, patients with conditions that reduce the possibility of enrolment or complicate enrolment, such as frequent changes in work environment, are prone to loss of follow\-up.

Outcomes

Primary Outcomes

Not specified

Similar Trials